Based on our results, FOXP3+ tumor infiltrating lymphocytes in OSCC may have a similar inhibitory effect as other solid tumors by inhibiting the cytotoxic activity of CD8+ T cells and affecting the response to immunotherapy. The gene discussed is CD8A; the disease is neoplasm.